101 – 110 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
(
- Contribution to journal › Article
-
Mark
Causal relationships between body mass index, smoking and lung cancer : Univariable and multivariable Mendelian randomization
(
- Contribution to journal › Article
-
Mark
Definition of Erythroid Differentiation Subsets in Normal Human Bone Marrow Using FlowSOM Unsupervised Cluster Analysis of Flow Cytometry Data
(
- Contribution to journal › Letter
-
Mark
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? : A population-based study
(
- Contribution to journal › Article
-
Mark
Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome
(
- Contribution to journal › Article
-
Mark
Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma
(
- Contribution to journal › Article
-
Mark
Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT
(
- Contribution to journal › Article
-
Mark
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
2021) In International Journal of Laboratory Hematology(
- Contribution to journal › Article